ETV re-treatment of nucleoside-naive HBeAG(-) patients

被引：4
|
作者：
Senturk, H.
Lurie, Y.
Gadano, A.
Tan, C. K.
Tran, T.
Lee, S. D.
Tsai, N.
Cheinquer, H.
Yang, J.
Tamez, R.
Hindes, R.
机构：
[1] Cerrahpasa Med Fac, Istanbul 0316, Turkey
[2] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
[3] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[4] Singapore Gen Hosp, Dept Gastroenterol, Singapore, 96822, Singapore
[5] Cedars Sinai Med Ctr, Los Angeles, CA USA
[6] Taipei Vet Gen Hosp, Taipei, 06492, Taiwan
[7] Univ Hawaii, Honolulu, HI 08543 USA
[8] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil
[9] Bristol Myers Squibb Co, Pharmaceut Res Inst, Wallingford, CT USA
[10] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ USA
来源：
JOURNAL OF HEPATOLOGY | 2007年 / 46卷
关键词：
D O I：
10.1016/S0168-8278(07)62115-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
517
引用
收藏
页码：S197 / S197
页数：1
相关论文
共 50 条
  • [1] Four-year entecavir treatment in nucleoside-naive HBeAg(+) patients: Results from studies ETV-022 and-901
    Han, Steven
    Chang, Ting-Tsung
    Chao, You-Chen
    Yoon, Seung-Kew
    Gish, Robert G.
    Cheinquer, Hugo
    Carrillho, Flair Jose
    Zhong, Hui
    Brett-Smith, Helena
    Hindes, Robert
    HEPATOLOGY, 2007, 46 (04) : 654A - 654A
  • [2] Entecavir is superior to lamivudine for the treatment of HBeAg(+) chronic hepatitis B: Results of phase III study ETV-022 in nucleoside-naive patients
    Chang, TT
    Gish, R
    de Man, R
    Gadano, A
    Sollano, J
    Han, KH
    Goodman, Z
    Zhu, J
    Cross, A
    Dehertogh, D
    Apelian, D
    HEPATOLOGY, 2004, 40 (04) : 193A - 193A
  • [3] Entecavir is superior to lamivudine for the treatment of HBeAg(+) chronic hepatitis B: results of Phase III study ETV-022 in nucleoside-naive patients
    Chang, TT
    Gish, R
    de Man, R
    Gadano, A
    Sollano, J
    Han, KH
    Goodman, Z
    Zhu, J
    Cross, A
    DeHertogh, D
    Apelian, D
    ANTIVIRAL THERAPY, 2004, 9 (06) : H21 - H22
  • [4] Four year assessment of ETV resistance in nucleoside-naive and lamivudine refractory patients
    Colonno, R. J.
    Rose, R. E.
    Pokornowski, K.
    Baldick, C. J.
    Eggers, B.
    Yu, D.
    Cross, A.
    Tenney, D. J.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S294 - S294
  • [5] 3 years of ETV re-treatment in HBeAg (-) patients who previously discontinued ETV treatment: results from study ETV-901
    Sievert, W.
    Shouval, D.
    Lai, C.
    Chang, T. T.
    Gadano, A.
    Wu, S.
    Halota, W.
    Tsai, N. C.
    Zhang, H.
    Iloeje, U.
    Munafo, L.
    Newman, J.
    Slade, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A273 - A273
  • [6] Entecavir demonstrates consistent responses among baseline subgroups in the treatment of nucleoside-naive, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B
    Brown, RS
    Lok, AS
    Gish, RG
    Schiff, ER
    Shouval, D
    Senturk, H
    Chang, TT
    Yurdaydin, C
    Apelian, D
    Fernandes, L
    Klesczewski, K
    Cross, AP
    Wilber, RB
    GASTROENTEROLOGY, 2005, 128 (04) : A737 - A738
  • [7] THREE YEARS OF ENTECAVIR (ETV) RE-TREATMENT OF HBEAG(-) ETV PATIENTS WHO PREVIOUSLY DISCONTINUED ETV TREATMENT: RESULTS FROM STUDY ETV-901
    Shouval, Daniel
    Lai, Ching-Lung
    Chang, Ting-Tsung
    Gadano, Adrian
    Wu, Shun-Sheng
    Halota, Waldemar
    Sievert, William
    Tsai, Naoky C. S. C.
    Zhang, Hui
    Iloeje, Uchenna
    HEPATOLOGY, 2008, 48 (04) : 722A - 723A
  • [8] FIVE YEARS OF CONTINUOUS ENTECAVIR FOR NUCLEOSIDE-NAiVE HBEAG(+) CHRONIC HEPATITIS B: RESULTS FROM STUDY ETV-901
    Han, Steven-Huy B.
    Chang, Ting-Tsung
    Chao, You-Chen
    Yoon, Seung Kew
    Gish, Robert G.
    Cheinquer, Hugo
    Kitis, George E.
    Zhang, Hui
    Iloeje, Uchenna
    HEPATOLOGY, 2008, 48 (04) : 705A - 706A
  • [9] The efficacy of entecavir is similar regardless of disease-related baseline subgroups in treatment of nucleoside-naive, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B
    Lurie, Y
    Manns, MP
    Gish, RG
    Chang, TT
    Yurdaydin, C
    Lai, CL
    Shouval, D
    Brown, RS
    Apelian, D
    Fernandes, L
    Klesczewski, K
    Cross, A
    Wilber, R
    JOURNAL OF HEPATOLOGY, 2005, 42 : 184 - 184
  • [10] Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B
    Gish, R. G.
    Chang, T. -T.
    Lai, C. -L.
    de Man, R.
    Gadano, A.
    Poordad, F.
    Yang, J.
    Brett-Smith, H.
    Tamez, R.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (01) : 16 - 22
12345